Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

Melanoma patients treated with anti-CTLA-4 have shown a range of anti-tumor responses. In this report, we describe the response of a single patient to anti-CTLA-4, with individual lesions disappearing, others stabilizing, and others progressing. These responses can be viewed as a clear manifestation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yuan, Jianda, Page, David B., Ku, Geoffrey Y., Li, Yanyun, Mu, Zhenyu, Ariyan, Charlotte, Gallardo, Humilidad F., Roman, Ruth-Ann, Heine, Agnes I., Terzulli, Stephanie L., Gnjatic, Sacha, Ritter, Gerd, Jungbluth, Achim A., Allison, James P., Old, Lloyd J., Wolchok, Jedd D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Academy of Cancer Immunology 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964016/
https://ncbi.nlm.nih.gov/pubmed/20052966
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak